EPISODE · Feb 25, 2025 · 43 MIN
Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research
from Strategy& Insider · host Thomas Solbach, Ghioia Irritier, Jan-Philipp Loch
In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.
What this episode covers
In this episode, we explore the forefront of rare disease research with Professor Matthew Wood, the Director and Chief Scientific Officer at the Oxford-Harrington Rare Disease Centre (OHC). Professor Wood shares his inspiring journey from his early studies in Cape Town to his impactful career at Oxford University. Learn about the innovative initiatives at OHC and their ambitious plan to bring 40 drugs into clinical trials within the next decade. This episode provides valuable insights into the challenges and opportunities in rare disease treatment, presenting a hopeful vision for rapid diagnosis and effective therapies.
NOW PLAYING
Strategy& Insider Episode 31 - Advancing breakthroughs in rare disease research
No transcript for this episode yet
Similar Episodes
May 7, 2026 ·8m
Apr 25, 2026 ·9m
Apr 24, 2026 ·5m
Apr 24, 2026 ·9m
Apr 24, 2026 ·11m